![Øystein Rekdal](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Øystein Rekdal
Vorstandsvorsitzender bei LYTIX BIOPHARMA
Aktive Positionen von Øystein Rekdal
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
LYTIX BIOPHARMA | Vorstandsvorsitzender | 11.09.2019 | - |
Gründer | 01.01.2003 | - | |
Direktor/Vorstandsmitglied | 26.04.2010 | 21.04.2011 | |
Technik-/Wissenschafts-/F&E-Leiter | - | 11.09.2019 | |
Corporate Officer/Principal | 01.01.2003 | - | |
University of Tromso | Corporate Officer/Principal | - | - |
Karriereverlauf von Øystein Rekdal
Ehemalige bekannte Positionen von Øystein Rekdal
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Prophylix AS
![]() Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Direktor/Vorstandsmitglied | 15.04.2010 | - |
Ausbildung von Øystein Rekdal
University of Tromso | Doctorate Degree |
Statistik
International
Norwegen | 4 |
Operativ
Director/Board Member | 2 |
Corporate Officer/Principal | 2 |
Chief Executive Officer | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
LYTIX BIOPHARMA | Health Technology |
Private Unternehmen | 1 |
---|---|
Prophylix AS
![]() Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Health Technology |
- Börse
- Insiders
- Øystein Rekdal
- Erfahrung